NCT02420314 2024-08-20Pharmacological Ascorbate for Lung CancerUniversity of IowaPhase 2 Completed55 enrolled 10 charts
NCT03799094 2019-01-10Vitamin C and Tyrosine Kinase Inhibitor in Lung Cancer Patients With Epidermal Growth Factor Receptor MutationsClifford Hospital, Guangzhou, ChinaPhase 1/2 Unknown150 enrolled